Pre-clinical evaluation of 2,3-dimercaptosuccinic acid as a radiation nephrotoxicity protective agent during radiopeptide therapy of neuroendocrine malignancy. [electronic resource]
Producer: 20070501Description: 261-6 p. digitalISSN:- 0143-3636
- Animals
- Body Burden
- Chelating Agents -- administration & dosage
- Drug Evaluation, Preclinical
- Kidney -- metabolism
- Kidney Diseases -- etiology
- Male
- Metabolic Clearance Rate -- drug effects
- Neuroectodermal Tumors -- metabolism
- Octreotide -- administration & dosage
- Organ Specificity
- Peptides -- administration & dosage
- Radiation Dosage
- Radiation Injuries -- etiology
- Radiation-Protective Agents -- administration & dosage
- Radiopharmaceuticals -- administration & dosage
- Rats
- Rats, Wistar
- Succimer -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.